Rhythm Biosciences Begins Structured Commercial Rollout of ColoSTAT®
Rhythm Biosciences (ASX: RHY) has enrolled the first physician participant in its ColoSTAT® Access Program, initiating structured commercial deployment of […]
Rhythm Biosciences (ASX: RHY) has enrolled the first physician participant in its ColoSTAT® Access Program, initiating structured commercial deployment of […]
Dateline Resources (ASX: DTR) has reported a wide gold intercept from diamond hole CM25-41 at its 100%-owned Colosseum Gold-REE Project